Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage.
about
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophiliaMetroplasty versus expectant management for women with recurrent miscarriage and a septate uterusMetroplasty versus expectant management for women with recurrent miscarriage and a septate uterusAspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndromeThe epidermal growth factor receptor critically regulates endometrial function during early pregnancy.ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trialNatural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss.Recurrent pregnancy loss: current perspectivesSeropositivity of cytomegalovirus in patients with recurrent pregnancy loss.The histidine-rich glycoprotein A1042G polymorphism and recurrent miscarriage: a pilot study.The Effects of Nitric Oxide Donors on Uterine Artery and Sub-endometrial Blood Flow in Patients with Unexplained Recurrent AbortionAcupuncture as a therapeutic treatment option for threatened miscarriage.Pregnancy loss and thrombophilia: the elusive link.Elevated periimplantation uterine natural killer cell density in human endometrium is associated with impaired corticosteroid signaling in decidualizing stromal cellsPhosphodiesterase 8B gene polymorphism in women with recurrent miscarriage: a retrospective case control studyDecline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy.New insights into mechanisms behind miscarriage.Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.Depression and emotional stress is highly prevalent among women with recurrent pregnancy lossMolecular analysis of products of conception obtained by hysteroembryoscopy from infertile couples.Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndromeGenetics of recurrent miscarriage: challenges, current knowledge, future directions.Detection of thrombophilic mutations related to spontaneous abortions by a multiplex SNaPshot methodRelationship between mean platelet volume and recurrent miscarriage: a preliminary studyEvaluation of Some Plasma Coagulation Factors in Women with Spontaneous Miscarriage.The -2549 insertion/deletion polymorphism in the promoter region of the VEGFA gene in couples with idiopathic recurrent spontaneous abortionIncreased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage.Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).Two-year outcome after recurrent first trimester miscarriages: prognostic value of the past obstetric history.Endocrine dysfunction and recurrent spontaneous abortion: An overview.Immunogenetic contributions to recurrent pregnancy lossAssociation of genetic variants in the 3'UTR of HLA-G with Recurrent Pregnancy Loss.Thrombophilia and anticoagulation in pregnancy: indications, risks and management.Chorionic gonadotropin beta-gene variants are associated with recurrent miscarriage in two European populations.Azithromycin prevents pregnancy loss: reducing the level of tumor necrosis factor-alpha and raising the level of interleukin-10 in rats.Predicting adverse obstetric outcome after early pregnancy events and complications: a review.RNA sequencing of chorionic villi from recurrent pregnancy loss patients reveals impaired function of basic nuclear and cellular machinery.Chromosomal abnormalities in couples with repeated fetal loss: An Indian retrospective study.CD107a Expression and IFN-γ Production as Markers for Evaluation of Cytotoxic CD3+ CD8+ T Cell Response to CMV Antigen in Women with Recurrent Spontaneous Abortion.Balanced Autosomal Translocations in Two Women Reporting Recurrent Miscarriage.
P2860
Q24194917-B40B6CAF-7D89-4233-95BE-D7DC6B804C03Q24236656-C653CFA0-093A-4E00-A325-BB47A44EA133Q24236767-C711B3B7-F834-4F3D-A61F-8EFA00A8364BQ24241127-1C16613B-12CF-4526-81E5-08248343648BQ30412338-6945C19A-E5B7-4819-8A5E-23B083E63949Q33422596-E1B35895-4E5D-4D1B-B4AB-5E9467CF43D5Q33565602-833FD4CE-1883-49BB-B4B6-ECE4135AF81AQ33713930-37170369-0696-43E9-BE11-E638F7E5CBD2Q33833216-6A1D629E-D022-46C0-A9AF-A572A7278D7BQ33986046-0B3A1F39-2C21-48E4-8C27-B2535ED04F34Q34067704-0A575CBC-D2AE-41DF-BAF8-229A48B11914Q34206965-55B994CE-CD72-4BFF-9BAA-CBA61E8E5836Q34263740-3EE7F296-21E7-46E0-B2A9-C57B34567FE8Q34396597-FCC6D09C-2180-4686-9E2D-43EDCF34183EQ34511624-0341497D-DF6B-46CD-AB2D-D00EAEAA552EQ34583580-19A0C882-4944-4D97-A184-D839BFBFA5D3Q34784972-AD7399B5-B96B-4508-BEAB-9B81F412C87AQ34989838-F215B570-613F-4456-9006-510779B9C72FQ35176648-CF153464-1433-4831-B00D-8AFB0FEECD42Q35599521-C383F763-3383-47F8-B2E4-5FA486C3DC4EQ35751482-0D3FE6F7-5356-43BA-BB9D-2DC0F6466B8EQ35837851-2FF8287B-D42A-4FD4-A43A-A64E601A1CFAQ35888683-4B595664-8AB7-4B5F-8095-8B0EDF5580FEQ36220584-5E6C3788-D2CA-4BFE-BBFB-2B040D1526EEQ36351263-2F2316C1-719D-442A-AF79-74084AEF2873Q36378500-C92567A0-D216-4395-BE91-F4FDF9319CD1Q36582116-4615AD1B-AE6C-4A92-A6D8-891A09061E9DQ36697714-0C07B38B-00EF-400E-BABD-99326040D109Q36792530-1F963B2C-8D62-45F1-9D1B-D65971233FAEQ36794012-5B09B718-1095-4CF2-884A-32034A06FF04Q37059982-4CC0C223-0622-4053-BE77-5FCA66DD52DFQ37252403-998EBB47-DC0F-4BE8-84C6-E3EC568645F9Q37326644-D2F4C667-BC0C-4329-8B36-400E827B0C7BQ37331451-4FD1AFA0-C0BF-4EA9-94FF-D8A7A348B739Q37383429-8294F66B-FDC6-4CF5-8B51-E8DB17D5DECEQ37409119-8A5C6101-1340-4960-B0DC-B5DC3E7D1410Q37483645-44BB1087-ED04-44A3-B169-A2406BCB1A22Q37498432-2332B5EF-6E9E-46D5-BD43-1FA1516306F3Q37512494-9C3E54B7-1E08-44C5-9726-8F749B704E76Q37630030-26C1DC85-0344-463D-887C-7E5A3F16B861
P2860
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Evidence-based guidelines for ...... ment of recurrent miscarriage.
@ast
Evidence-based guidelines for ...... ment of recurrent miscarriage.
@en
type
label
Evidence-based guidelines for ...... ment of recurrent miscarriage.
@ast
Evidence-based guidelines for ...... ment of recurrent miscarriage.
@en
prefLabel
Evidence-based guidelines for ...... ment of recurrent miscarriage.
@ast
Evidence-based guidelines for ...... ment of recurrent miscarriage.
@en
P2093
P356
P1433
P1476
Evidence-based guidelines for ...... ment of recurrent miscarriage.
@en
P2093
Eric Jauniaux
Niek Exalto
Ole B Christiansen
Roy G Farquharson
P304
P356
10.1093/HUMREP/DEL150
P407
P577
2006-05-17T00:00:00Z